Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

The document concludes that better training and education are needed for proper cancer screening and criticizes the GMC's inaction as harmful to clinical ethics in the UK.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Living near more dermatologists and using certain cancer screening tests lowers the chance of being diagnosed with advanced skin cancer.

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

CT scans can find serious prostate cancer even when PSA levels are low.

The document listed medical job ads and guidelines for breast cancer screening.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Breast cancer may be detectable through changes in scalp hair lipids.

Women with alopecia may have a higher chance of getting thyroid cancer.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Hair transplant surgeons should also focus on their patients' overall health, including regular check-ups and screening for common health issues.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.